Results 181 to 190 of about 11,454 (213)
Some of the next articles are maybe not open access.

Indoxyl Sulfate Induces Nephrovascular Senescence

Journal of Renal Nutrition, 2012
Indoxyl sulfate is markedly accumulated in the serum of chronic kidney disease (CKD) patients. The oral sorbent AST-120 reduces serum levels of indoxyl sulfate in CKD patients by adsorbing indole, a precursor of indoxyl sulfate, in the intestine. Indoxyl sulfate is taken up by proximal tubular cells through organic anion transporters (OAT1, OAT3), and ...
Toshimitsu, Niwa, Hidehisa, Shimizu
openaire   +2 more sources

Growth-Promoting Activity of Potassium Indoxyl Sulfate and Indoxyl Acetate

Botanical Gazette, 1954
1. In this paper exploratory experiments have been described in which some oxidized indole derivatives have stimulated slightly the growth of corn coleoptile sections. 2. When potassium indoxyl sulfate and indoxyl acetate were supplied, light appeared to modify greatly the growth response. 3. Whether considered as degradation products in the metabolism
Richard C. French, Harry Beevers
openaire   +1 more source

Indoxyl Sulfate and Arteriosclerosis

2020
The uremic toxin indoxyl sulfate, metabolized from dietary tryptophan, accumulates in the serum of patients with decreased renal function. A higher level of serum indoxyl sulfate is reported to be an independent risk factor for cardiovascular events and death in patients with chronic kidney disease.
openaire   +1 more source

Indoxyl Sulfate Is a Nephro-Vascular Toxin

Journal of Renal Nutrition, 2010
Indoxyl sulfate is markedly accumulated in the serum of patients with chronic kidney disease (CKD). The oral sorbent AST-120 reduces the serum levels of indoxyl sulfate in CKD patients by adsorbing indole, a precursor of indoxyl sulfate, in the intestine, and thereby stimulating its excretion in feces. AST-120 is used for the treatment of patients with
openaire   +2 more sources

Engineered binding sites for indoxyl sulfate and p-cresol sulfate

2023
The removal of uremic toxins is of great importance in preventing the progression of chronic kidney disease. The investigation of the interaction of uremic toxins with serum and dialysis materials will contribute to the advancement of techniques in uremic toxins removal.
openaire   +1 more source

Performance evaluation of an Indoxyl Sulfate Assay Kit “NIPRO”

Clinical Chemistry and Laboratory Medicine (CCLM), 2019
Abstract Background The relationship between renal disease and cardiovascular disease (CVD) is currently known as cardiorenal syndrome. Indoxyl sulfate (IS) is one of the uremic toxins that accelerates the progression of cardiorenal syndrome.
Yuki, Fushimi   +5 more
openaire   +2 more sources

Indoxyl Sulfate and Atherosclerotic Risk Factors in Hemodialysis Patients

American Journal of Nephrology, 2007
<i>Background:</i> Indoxyl sulfate is a uremic toxin that accelerates the progression of chronic kidney disease (CKD). Serum levels of indoxyl sulfate are increased in dialysis patients. It was reported that indoxyl sulfate plays a role in endothelial dysfunction in uremic patients, and stimulates proliferation of rat vascular smooth muscle
Kentaro, Taki   +2 more
openaire   +2 more sources

Indoxyl sulfate, a uremic toxin, is biotransformed from indoxyl-β-d-glucoside (indican) in rats

Toxicon, 2008
Indican (Indoxyl-beta-D-glucoside) is present in many Chinese herbs such as Isatis indigotica, Clerodendrum crytophyllum, Glehnia littoralis, Polygonum tinctorium and P. perfoliatum. This study aims to investigate whether indoxyl sulfate, a uremic toxin, would be biotransformed from indican in rats.
Yu-Chi, Hou   +4 more
openaire   +2 more sources

Effect of uremic toxin-indoxyl sulfate on the skeletal system

Clinica Chimica Acta, 2018
Chronic kidney disease-mineral bone disorders (CKD-MBD) exhibit abnormalities in the circulating mineral levels, vitamin D metabolism, and parathyroid function that contribute to the formation of a bone lesion. The uremic toxin, indoxyl sulfate (IS), accumulates in the blood in cases of renal failure and leads to bone loss. The bone and renal responses
Wen-Chih, Liu   +8 more
openaire   +2 more sources

Association Between Indoxyl Sulfate and Skeletal Resistance in Hemodialysis Patients

Therapeutic Apheresis and Dialysis, 2010
AbstractSkeletal resistance to parathyroid hormone (PTH) in uremia is known, although the mechanism of resistance is not fully elucidated. To clarify the roles of indoxyl sulfate, which is a uremic toxin, in skeletal resistance, we examined the relationship between indoxyl sulfate and biochemical markers of bone turnover in hemodialysis patients.
Shunsuke, Goto   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy